Allergan Aesthetics Cuts 202 Jobs Amid Sales DipAbbvieAbbVie’s Allergan Aesthetics plans to lay off 202 employees following a decline in Botox and Juvederm sales. The restructuring aims to strengthen the company’s position in the competitive aesthetics market.
SKYRIZI? Approved for Ulcerative Colitis Treatment by FDAAbbvieSKYRIZI? (risankizumab-rzaa) approval by the FDA marks a milestone in treating ulcerative colitis and Crohn's disease, highlighting clinical trials, impact on patients, and safety considerations.